(Q41050922)

English

IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway

scientific article published on March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway (English)

1 reference

Europe PubMed Central

26 September 2017

5

1 reference

Europe PubMed Central

26 September 2017

author name string

M Bergmann

1

1 reference

Europe PubMed Central

26 September 2017

L Hart

2

1 reference

Europe PubMed Central

26 September 2017

M Lindsay

3

1 reference

Europe PubMed Central

26 September 2017

P J Barnes

4

1 reference

Europe PubMed Central

26 September 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

26 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

26 September 2017

273

1 reference

Europe PubMed Central

26 September 2017

6607-6610

1 reference

Europe PubMed Central

26 September 2017

12

1 reference

Europe PubMed Central

26 September 2017

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Catalysis by a multiprotein IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Characterization of IkappaB kinases. IkappaB-alpha is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1beta and NFkappaB activation, but not NFkappaB nuclear translocation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Superinduction of NF-kappa B by actinomycin D and cycloheximide in epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

NF-kappaB activation: the I kappaB kinase revealed?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Cell death induction by receptors of the TNF family: towards a molecular understanding.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

The protein tyrosine kinase Fyn activates transcription from the HIV promoter via activation of NF kappa B-like DNA-binding proteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Dissociation of tyrosine phosphorylation and activation of phosphoinositide phospholipase C induced by the protein kinase C inhibitor Ro-31-8220 in Swiss 3T3 cells treated with platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.12.6607

21 January 2018

Identifiers

10.1074/JBC.273.12.6607

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41050922&oldid=1913669711"